Skip to content

Opko Health OPK Price / book

Price / book at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
2.9×+0.2×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
2.7×+2.0×
HRO
HarrowHROW
45.7×+28.9×
Precigen logo
PrecigenPGEN
67.7×
Immunome logo
ImmunomeIMNM
4.2×+2.3×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
316.5×+303×

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B+10.0%
P/S1.9×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Calculated from Opko Health’s reported figures.

Based on the most recent quarter.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's price / book?
Opko Health (OPK) reported price / book of 0.7× in Q1 2026.
How has Opko Health's price / book changed year-over-year?
Opko Health's price / book decreased by 15.5% year-over-year, from 0.8× to 0.7×.
What is the long-term trend for Opko Health's price / book?
Over 5 years (2020 to 2025), Opko Health's price / book has grown at a -12.8% compound annual growth rate (CAGR), from 1.5× to 0.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.